Amanote Research

Amanote Research

    RegisterSign In

Structure and Optimization of Checkpoint Inhibitors

Cancers - Switzerland
doi 10.3390/cancers12010038
Full Text
Open PDF
Abstract

Available in full text

Categories
Cancer ResearchOncology
Date

December 21, 2019

Authors
Sarah L. PicardoJeffrey DoiAaron R. Hansen
Publisher

MDPI AG


Related search

Immune Checkpoint Inhibitors and irAEs

Trends in Immunotherapy
2018English

Fragment-Based and Structure-Guided Discovery and Optimization of Rho Kinase Inhibitors

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2012English

Hyperprogression and Immune Checkpoint Inhibitors: Hype or Progress?

Oncologist
Cancer ResearchMedicineOncology
2019English

Immune Checkpoint Inhibitors in Melanoma: Review and Update

Journal of the Portuguese Society of Dermatology and Venereology
2018English

Review of Cancer Treatment With Immune Checkpoint Inhibitors

Wiener Klinische Wochenschrift
Medicine
2017English

Association of Hemophagocytic Lymphohistiocytosis and Programmed Death 1 Checkpoint Inhibitors

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2019English

Immune Checkpoint Inhibitors for Metastatic Bladder Cancer

Cancer Treatment Reviews
MedicineOncologyRadiologyNuclear MedicineImaging
2018English

Rare Heart Risk Found With Checkpoint Inhibitors

Cancer
Cancer ResearchOncology
2017English

Are We Over-Treating With Checkpoint Inhibitors?

British Journal of Cancer
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy